INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th
Rhea-AI Summary
INNOVATE Corp (NYSE: VATE) will report its fourth quarter and full year 2025 results on March 26, 2026 after market close. A live earnings conference call will follow at 4:30 p.m. ET the same day and will be webcast on the company Investor Relations website.
Dial-in and replay details are provided for domestic and international participants; a replay will be available through April 9, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – VATE
In the Mar 17 session, VATE gained 1.90%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 10 | MediBeacon recognition | Positive | -1.5% | MediBeacon TGFR article named 2025 JASN Editors’ Choice cover feature. |
| Feb 02 | Portfolio dividend news | Positive | +3.2% | DBM Global cash dividend with INNOVATE expecting about $4.6M of payout. |
| Dec 16 | FDA approval | Positive | +3.9% | FDA approval for MediBeacon next‑generation TGFR System with reusable sensor. |
| Nov 12 | Q3 2025 earnings | Positive | +2.4% | Q3 2025 revenue and EBITDA growth with narrower net loss reported. |
| Oct 22 | Earnings date notice | Neutral | -1.5% | Announcement of Q3 2025 release date and earnings conference call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive fundamental or regulatory news (earnings, FDA approval, dividend) has generally seen aligned positive moves, while a MediBeacon recognition article saw a mild negative divergence.
Over the last six months, INNOVATE has reported stronger Q3 2025 results, highlighted by revenue growth and improved EBITDA, and secured FDA approval for MediBeacon’s next‑generation TGFR System. A portfolio company dividend and MediBeacon recognition in JASN further underscored portfolio activity. Earnings-date announcements, like the Q3 2025 reporting schedule, drew only modest reaction. Today’s Q4 and full-year 2025 earnings date notice fits this pattern of procedural communications ahead of more consequential financial updates.
Key Terms
investor relations financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2025 on Thursday, March 26, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.
Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE’s Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the “Investor Relations” portion of the INNOVATE website.
Conference Call Details
Live Call
Domestic Dial-In: 1-877-704-4453
Toll/International: 1-201-389-0920
Conference Replay*
Domestic Dial-In: 1-844-512-2921
Toll/International: 1-412-317-6671
Conference Number: 13758932
*Available approximately three hours after the end of the conference call through April 9, 2026.
About INNOVATE
INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 3,100 people across its subsidiaries. For more information, please visit: www.INNOVATECorp.com.
Investor Contact:
Solebury Strategic Communications
Anthony Rozmus
ir@innovatecorp.com
(212) 235-2691
